Prevalence and risk factors associated to tuberculosis and non-tuberculous mycobacterial infections in HIV-positive patients in Bogotá

Magda Beltrán-León, Francy Pérez-Llanos, Liliana Sánchez, Carlos Parra-López, Myriam Navarrete, Ricardo Sánchez, Carlos Awad, Ana María Granada, Edgardo Quintero, Óscar Briceño, Óscar Cruz, Martha Isabel Murcia, .

Keywords: Tuberculosis, Mycobacterium infections, acquired immunodeficiency syndrome, risk factors, prevalence, Colombia.

Abstract

Introduction. Tuberculosis is one of the most widely distributed infectious diseases worldwide. It is the most common cause of mortality among AIDS patients. In Colombia, 12,918 tuberculosis cases were notified, and 926 deaths were reported in 2015.
Objective. To determine the prevalence and risk factors associated to mycobacterial infections in HIVpositive patients in two public hospitals from Bogotá.
Materials and methods. A prospective and descriptive study was carried out by an active search for tuberculosis cases and non-tuberculous mycobacterial infections in HIV-positive patients. We considered demographic, social, clinical, and personal habits as variables. Statistical analyses were done using Stata 13™ software.
Results. Three hundred and fifty six patients were included, 81.2% were men and 18.8% were women; the mean age was 36.5 years. Tuberculosis infection had a frequency of 19.9% (95% CI: 15.9-24.5%) and non-tuberculous mycobacterial infection had a 3.9% frequency (95% CI: 2.16-6.5%). Bivariate analysis showed a statistically significant association between tuberculosis infection and CD4+ T cell counts (p=0.003), viral load (p=0.008), antiretroviral therapy (p=0.014), and body mass index (BMI) <18 kg/m2 (p=0.000). In non-tuberculous mycobacterial infections there was a statistically significant
association with BMI (p=0.027) and CD4+ T cell counts (p=0.045).
Conclusion. Factors associated with an impaired immune system caused by HIV infection are an important risk factor for developing tuberculosis. The lack of antiretroviral therapy and the BMI were also important risk factors for tuberculosis.

Downloads

Download data is not yet available.
  • Magda Beltrán-León Departamento de Microbiología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombia
  • Francy Pérez-Llanos Departamento de Microbiología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombia
  • Liliana Sánchez Departamento de Microbiología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombia
  • Carlos Parra-López Departamento de Microbiología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombia
  • Myriam Navarrete Departamento de Microbiología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombia
  • Ricardo Sánchez Departamento de Psiquiatría, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombia
  • Carlos Awad Grupo VIH-TB Hospital Santa Clara, Bogotá, D.C., Colombia
  • Ana María Granada Grupo VIH-TB Hospital Santa Clara, Bogotá, D.C., Colombia
  • Edgardo Quintero Grupo VIH-TB Hospital Simón Bolívar, Bogotá, D.C., Colombia
  • Óscar Briceño Grupo VIH-TB Hospital Simón Bolívar, Bogotá, D.C., Colombia
  • Óscar Cruz Programa Distrital de Control de TB y Lepra, Secretaría Distrital de Salud, Bogotá, D.C., Colombia
  • Martha Isabel Murcia Departamento de Microbiología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombia

References

Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: Global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163:1009-21. https://doi.org/10.1001/archinte.163.9.1009

Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999;282:677-86. https://doi.org/10.1001/jama.282.7.677

World Health Organization.Global tuberculosis report 2015. Fecha de consulta: 12 de febrero de 2016. Disponible en: apps.who.int/iris/bitstream/10665/191102/1/9789241565059_

eng.pdf

Organización Mundial de la Salud, Organización Panamericana de la Salud. Plan Estratégico Colombia Libre de Tuberculosis 2010-2015 para la expansión y fortalecimiento de la estrategia Alto a la TB. Fecha de consulta: 12 de octubre de 2015. Disponible en: http://www.paho.org/col/index.php?option=com_docman&task=doc_

download&gid=327&Itemid=

Ticona-Mendoza A, Iglesias-Quilca D. Tuberculosis en pacientes con VIH/SIDA. Acta Médica Peruana. 2008;25:247-54

Castiblanco CA, Wllman R. Coinfección de tuberculosis en pacientes con VIH/SIDA: un análisis según las fuentes de información en Colombia. Infectio. 2006;10:232-42.

Castiblanco CA, Llerena C. Tuberculosis en Colombia: análisis de la situación epidemiológica, año 2006. Infectio. 2008;12:159-73

Ministerio de Salud y Protección Social. Análisis de situación de salud. Colombia, 2014. Fecha de consulta: 3 de abril de 2016. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/ED/PSP/ASIS-2014-v11.pdf

Instituto Nacional de Salud. Boletín Epidemiológico Semanal. Diciembre 2015. Reporte No. 52. Fecha de consulta: 20 de febrero de 2016. Disponible en: http://www.ins.gov.co/boletin-epidemiologico/Boletn%20Epidemiolgico/2015%20Boletin%20epidemiologico%20Semana%2052.pdf

Peñuela-Epalza M, Vásquez-Beltrán M, De La Rosa-Barraza K, Hernández-Tapia H, Collazos-Daza J, Yanes-Miranda Y. Factores asociados a la coinfección VIH/SIDAtuberculosis. Salud Uninorte. 2006;22:5-19.

Villarroel L, Rabagliati R, Balcells ME, Karzulovic L, Pérez C. Tuberculosis en individuos con infección por VIH en Chile: estudio de prevalencia e impacto sobre mortalidad. Rev Med Chil. 2008;136:578-86. https://doi.org/10.4067/S0034-98872008000500005

Laguardia J, Merchán-Hamann E. Factores de riesgo para la enfermedad tuberculosa en los casos de sida notificados en Brasil, 1980 a 2000. Rev Esp Salud Pública. 2003;77:553-65.

Organización Panamericana de la Salud. Manual para el diagnóstico bacteriológico de la tuberculosis. Organización Panamericana de la Salud - 2008. Fecha de consulta:

de noviembre de 2015. Disponible en: iris.paho.org/xmlui/bitstream/handle/123456789/782/9789275330135.pdf?sequence=1&isAllowed=y.

World Health Organization. Global tuberculosis report 2014. Fecha de consulta: 1 de octubre de 2015. Disponible en: apps.who.int/iris/bitstream/10665/137094/1/9789241564809_

eng.pdf

Ministerio de Salud. Resolución Número 1078 de 2000. Fecha de consulta: 12 de febrero de 2016. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/

BibliotecaDigital/RIDE/DE/DIJ/Resoluci%C3%B3n_1078_de_2000.pdf

López-Álvarez R, Badillo-López C, Cerna-Cortés JF, Castillo-Ramírez I, Rivera-Gutiérrez S, Helguera-Repetto AC, et al. First insights into the genetic diversity of Mycobacterium tuberculosis isolates from HIV-infected Mexican patients and mutations causing multidrug resistance. BMC Microbiol. 2010;10:82. https://doi.org/10.1186/1471-2180-10-82

Martinson NA, Hoffmann CJ, Chaisson RE. Epidemiology of tuberculosis and HIV: Recent advances in understanding and responses. Proc Am Thorac Soc. 2011;8:288-93.

https://doi.org/10.1513/pats.201010-064WR

World Health Organization. HIV/AIDS: 2015. Fecha de consulta: 25 de enero 25 de 2016. Disponible en: http://www.who.int/mediacentre/factsheets/fs360/en/

Crespo MP, Heli-Corral R, Alzate A, Carrasquilla G, Sánchez N. Mycobacterial infections in HIV-infected patients in Cali, Colombia. Rev Panam Salud Pública. 1999;6:249-55.

Murcia-Aranguren MI, Gómez-Marín JE, Alvarado FS, Bustillo JG, de Mendivelson E, Gómez B, et al. Frequency of tuberculous and non-tuberculous mycobacteria in HIV infected patients from Bogotá, Colombia. BMC Infect Dis. 2001;1:21.

Schmaltz CA, Santoro-Lopes G, Lourenço MC, Morgado MG, Velasque Lde S, Rolla VC. Factors impacting early mortality in tuberculosis/HIV patients: Differences between subjects naive to and previously started on HAART. PloS One. 2012;7:e45704. https://doi.org/10.1371/journal.pone.0045704

Taha M, Deribew A, Tessema F, Assegid S, Duchateau L, Colebunders R. Risk factors of active tuberculosis in people living with HIV/AIDS in Southwest Ethiopia: A case control study. Ethiop J Health Sci. 2011;21:131-9.

Murcia MI, León CI, de la Hoz F, Saravia J. Mycobacteria-HIV/AIDS association in patients attending a teachinghospital in Bogotá, Colombia. Rev Salud Pública. 2007;9:97-105. https://doi.org/10.1590/S0124-00642007000100010

Arenas NE, Ramírez N, González G, Rubertone S, García AM, Gómez-Marínc JE, et al. Estado de la coinfección tuberculosis/virus de la inmunodeficiencia humana en el municipio de Armenia (Colombia): experiencia de 10 años. Infectio. 2012;16:140-7.

Hoza AS, Mfinanga SG, Rodloff AC, Moser I, Konig B. Increased isolation of nontuberculous mycobacteria among TB suspects in Northeastern, Tanzania: Public health and diagnostic implications for control programmes. BMC Res Notes. 2016;9:109. https://doi.org/10.1186/s13104-016-1928-3

Kobayashi T, Nishijima T, Teruya K, Aoki T, Kikuchi Y, Oka S, et al. High mortality of disseminated non-tuberculous mycobacterial infection in HIV-infected patients in the antiretroviral therapy era. PloS One. 2016;11:e0151682. https://doi.org/10.1371/journal.pone.0151682

Lan R, Yang C, Lan L, Ou J, Qiao K, Liu F, et al. Mycobacterium tuberculosis and non-tuberculous mycobacteria isolates from HIV-infected patients in Guangxi, China. Int J Tuberc Lung Dis. 2011;15:1669-75. https://doi.org/10.5588/ijtld.11.0036

Lannoy LH, Cortéz-Escalante JJ, Evangelista MS, Romero GA. Tuberculosis incidence and risk factors among patients living with HIV/AIDS in public health service institutions in Brasilia, Federal District. Rev Soc Bras Med Trop. 2008;41:549-55. https://doi.org/10.1590/S0037-86822008000600001

How to Cite
1.
Beltrán-León M, Pérez-Llanos F, Sánchez L, Parra-López C, Navarrete M, Sánchez R, et al. Prevalence and risk factors associated to tuberculosis and non-tuberculous mycobacterial infections in HIV-positive patients in Bogotá. biomedica [Internet]. 2018 Mar. 15 [cited 2024 May 16];38(1):120-7. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/3410

Some similar items:

tuberculosis; infecciones por Mycobacterium; síndrome de inmunodeficiencia adquirida; factores de riesgo; prevalencia; Colombia
Published
2018-03-15
Section
Original articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code